Skip to main content
. 2022 Apr 28;44(1):731–740. doi: 10.1080/0886022X.2022.2068442

Table 3.

Clinical presentation and prognosis of groups regarding to different glomerular PLA2R antigen intensity.

  Glomerular PLA2R positive Glomerular PLA2R negative
(n = 114) (n = 41)
Serum albumin 22.2 ± 6.1 23.4 ± 7.9
Urinary protein 4.8 ± 2.1* 3.6 ± 1.7*
Serum anti-PLA2R positive 69/114 (60.5%) 27/41 (65.9%)
Serum anti-PLA2R titer 99.3 ± 118.9 86.9 ± 186.6
Renal IgG4 semi-quantity 1.7 ± 0.57* 1.6 ± 0.76*
NR 35/92 (38.0%) 15/33 (45.5%)
PR/CR 57/92 (62.0%) 18/33 (54.5%)
CR 33/92 (35.9%) 9/33 (27.3%)

*p < 0.05, glomerular PLA2R positive versus glomerular PLA2R negative.

CR: complete remission; PR: partial remission; NR: no response.